CervoMed CRVO
NASDAQ CRVO
$2.62 +0.06 (+2.15%)
As of: Aug 21, 2026 · 1:03 PM EDT

CervoMed (CRVO) Operating Leases (2019 - 2021)

CervoMed (CRVO) posted Operating Leases of $8819.0 for Q1 2021, down 75.29% sequentially from $35693.0 in Q4 2020, and down 92.11% YoY from $111787.0 in Q1 2020.

CervoMed (CRVO) Operating Leases (2019 - 2021) Analysis & Trends

CervoMed has reported Operating Leases for 3 years, with the latest figure at $8819.0 in Q1 2021.

  • Quarterly Operating Leases fell 92.11% year-over-year to $8819.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $8819.0 (down 92.11% YoY) and the FY2020 annual result came in at $35693.0, down 73.67% from the prior year.
  • Operating Leases retreated to $8819.0 in Q1 2021 per CRVO's latest filing, from $35693.0 in the prior quarter.
  • Over five years, Operating Leases peaked at $313364.0 in Q1 2019 and troughed at $8819.0 in Q1 2021.
  • A 3-year average of $138207.1 and a median of $111787.0 in 2020 frame the typical range for Operating Leases.
  • The sharpest annual moves came in 2020 and 2021: Operating Leases sank 64.33% in 2020, then tumbled 92.11% in 2021.
  • Over 3 years, Operating Leases stood at $135566.0 in 2019, then sank by 73.67% to $35693.0 in 2020, then plunged by 75.29% to $8819.0 in 2021.
  • According to Business Quant data, Operating Leases over the past three periods registered $8819.0, $35693.0, and $61715.0 for Q1 2021, Q4 2020, and Q3 2020 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.66 Bn 131.80 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.52 Bn 78.53 Bn 3.93 Bn
3 Argenx Se 65.33 Bn 60.14 Bn 1.37 Bn
4 Moderna 59.76 Bn 54.62 Bn 52.00 Mn
5 BeOne Medicines 42.15 Bn 37.05 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.84 Bn 28.53 Bn 992.69 Mn
7 BioNTech SE 28.23 Bn 9.84 Bn 668.28 Mn
8 Insmed 27.52 Bn 26.36 Bn 358.27 Mn
9 Royalty Pharma 27.29 Bn 26.46 Bn -
10 CervoMed 26.79 Mn 26.79 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2021 67,886.00
Jun 30, 2021 95,829.00
Mar 31, 2021 8,819.00
Dec 31, 2020 35,693.00
Sep 30, 2020 61,715.00
Jun 30, 2020 85,071.00
Mar 31, 2020 111,787.00
Dec 31, 2019 135,566.00
Sep 30, 2019 200,000.00
Jun 30, 2019 291,849.00
Mar 31, 2019 313,364.00